Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J unveils new obesity, arthritis collaborations, shares its molecule library
Fierce Biotech
Thu, 06/15/17 - 09:43 am
Tags:
JNJ, obesity, rheumatoid arthritis, molecules, molecule library, drug development
Johnson & Johnson's flu drug succeeds in mid-stage trial
Reuters
Wed, 06/14/17 - 09:56 pm
Tags:
JNJ, clinical trials, influenza, Flu
AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study
Fierce Pharma
Wed, 06/14/17 - 09:00 pm
Tags:
AstraZeneca, Boehringer Ingelheim, JNJ, Invokana, diabetes, Jardiance, amputation
J&J, Pfizer, Merck sit atop Fortune's 500 for pharma
BioPharma Dive
Wed, 06/14/17 - 11:58 am
Tags:
JNJ, Pfizer, Merck, Fortune 500, PBMs
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
Tags:
JNJ, Invokana, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
ADA 2017 Roundup: J&J inks dev deal with Qualcomm, launches next-gen OneTouch Reveal app
Mass Device
Tue, 06/13/17 - 04:14 pm
Tags:
diabetes, JNJ, Qualcomm, OneTouch Vario Flex, blood glucose monitoring, devices
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
Tags:
diabetes, Merck, Pfizer, SGLT2 inhibitor, Januvia, Invokana, Farxiga, Jardiance, Eli Lilly, Boehringer Ingelheim, AstraZeneca, JNJ
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Fierce Pharma
Tue, 06/13/17 - 11:55 am
Tags:
JNJ, Bayer, Xarelto, bloodthinners
J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes
Forbes
Mon, 06/12/17 - 10:15 pm
Tags:
JNJ, heart attacks, Invokana, diabetes, amputation. Eli Lilly, Boehringer Ingelheim, Jardiance
J&J’s Ethicon wins Philly pelvic mesh trial
Mass Device
Mon, 06/12/17 - 10:11 pm
Tags:
JNJ, Ethicon, pelvic mesh, devices
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
Tags:
ADA, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim, Lantus, Tresiba, JNJ, Novo Nordisk, PCSK9 inhibitors, Amgen Regeneron, Sanofi, Apple, Google, insulin
Johnson & Johnson wins last regulatory nod needed for Actelion acquisition
Drug Delivery Business News
Sat, 06/10/17 - 12:14 pm
Tags:
JNJ, Actelion, M&A, EU, Europe
Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another
Fierce Biotech
Thu, 06/8/17 - 09:38 am
Tags:
JNJ, Actelion, clinical trials, M&A, antibiotics, cadazolid
Early use of J&J's Zytiga extends prostate cancer survival
Yahoo/Reuters
Sun, 06/4/17 - 11:46 am
Tags:
JNJ, Zytiga, prostate cancer, ASCO 2017
Ohio suit will be 'tough to win' for opioid drugmakers, analyst says
Fierce Pharma
Sun, 06/4/17 - 11:37 am
Tags:
Ohio, opioids, Teva, Allergan, JNJ, Purdue, Endo Health Solutions
J&J's Zytiga slashes death risk by 38% in earlier-stage prostate cancer patients
Fierce Pharma
Sat, 06/3/17 - 09:23 am
Tags:
JNJ, Zytiga, prostate cancer, ASCO 2017
Minerva shares jump as J&J hands over $30M, revises insomnia drug pact; Iroko lays off 122
Endpoints
Sat, 06/3/17 - 09:17 am
Tags:
Minerva Neurosciences, MIN-202, JNJ, Actelion, insomnia, Iroko Pharmaceuticals
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
CNBC
Wed, 05/31/17 - 10:54 pm
Tags:
Ohio, opioid crisis, opioids, opioid abuse, JNJ, Janssen, Teva Pharmaceutical, Purdue Pharma, Allergan, Endo Health Solutions
Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug
Fierce Biotech
Tue, 05/30/17 - 06:20 pm
Tags:
JNJ, Protagonist Therapeutics, M&A, Crohn's Disease, PTG-200
Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data
Motley Fool
Tue, 05/30/17 - 10:05 am
Tags:
JNJ, Invokana, type 2 diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.